Diagnosis requires strong clinical and biochemical evidence of endogenous hyperinsulinemia and negative screening for oral hypoglycaemic agents and insulin antibodies before attempting to perform tumour localization studies, since most tumours are <1 cm in diameter and therefore not always detected on traditional imaging methods such as CT or MRI [5]. This evidence concerns the gene INS and hyperinsulinism.